Name: Senti Biosciences, Inc. (SNTI) Balance Sheet
Creator: FinSpry

Senti Biosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Senti Biosciences, Inc. (SNTI) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	48.28	35.93	57.62	56.03	30.54
Short-Term Investments	0.00	0.04	42.15	1.16	0.03
Cash & Short-Term Investments	48.28	35.93	99.77	57.19	30.56
Accounts Receivable	1.81	17.70	0.63	0.48	0.32
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	8.88	1.82	1.87	0.80	0.00
Total Current Assets	58.96	71.20	102.58	60.19	31.71
Non-Current Assets
Property, Plant & Equipment (Net)	35.24	41.61	69.78	33.08	16.14
Other Non-Current Assets	3.64	0.22	8.43	3.43	0.50
Total Non-Current Assets	38.88	42.95	74.85	36.51	0.00
Total Assets	97.84	119.48	180.79	96.70	48.35
Current Liabilities
Accounts Payable	1.45	7.18	1.37	5.19	0.91
Short-Term Debt	4.75	0.00	0.00	0.00	0.00
Accrued Liabilities	6.27	5.93	12.58	5.33	2.00
Deferred Revenue	0.66	0.99	0.80	1.66	0.00
Other Current Liabilities	6.28	0.39	1.32	0.63	0.44
Total Current Liabilities	13.15	12.67	18.05	14.54	4.87
Non-Current Liabilities
Long-Term Debt	28.89	33.54	35.10	20.99	0.00
Other Non-Current Liabilities	30.16	1.01	0.37	0.62	0.00
Total Non-Current Liabilities	59.05	40.88	35.61	193.62	0.00
Total Liabilities	72.19	52.57	53.53	36.33	17.40
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-297.13	-244.34	-173.29	-115.08	-59.76
Accumulated Other Comprehensive Income	0.00	0.00	0.00	0.00	0.00
Additional Paid-in Capital	322.78	311.26	300.54	3.62	0.00
Shares Outstanding	4.83	4.57	4.41	4.37	0.00
Total Stockholders' Equity	25.65	66.91	127.26	60.38	30.95
Total Liabilities & Equity	97.84	119.48	180.79	96.70	0.00